SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in GPCR — Structure Therapeutics Inc.
CIK 1446194
BALA CYNWYD, PA
Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,691,584
+$2,065,704 QoQ
Shares Held
55,842
+520.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Mar 31, 2026CallValue
$9,962,940
CallShares
206,700
PutValue
$5,663,500
PutShares
117,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. GPCR ranks #89 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in GPCR
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,691,584 | 55,842 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $5,663,500 | 117,500 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $9,962,940 | 206,700 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $625,880 | 8,999 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $8,603,335 | 123,700 | Put | Other | 2026-02-17 | |
| 2025-12-31 | $16,420,755 | 236,100 | Call | Other | 2026-02-17 | |
| 2025-09-30 | $6,633,200 | 236,900 | Call | Other | 2025-11-14 | |
| 2025-09-30 | $6,860,000 | 245,000 | Put | Other | 2025-11-14 | |
| 2025-09-30 | $5,981,024 | 213,608 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,572,133 | 75,802 | Shares | Other | 2025-08-14 | |
| 2025-06-30 | $2,212,958 | 106,700 | Call | Other | 2025-08-14 | |
| 2025-06-30 | $2,200,514 | 106,100 | Put | Other | 2025-08-14 | |
| 2025-03-31 | $1,739,655 | 100,500 | Call | Other | 2025-05-14 | |
| 2025-03-31 | $1,179,970 | 68,167 | Shares | Other | 2025-05-14 | |
| 2025-03-31 | $2,381,856 | 137,600 | Put | Other | 2025-05-14 | |
| 2024-12-31 | $1,849,665 | 68,203 | Shares | Other | 2025-02-14 | |
| 2024-12-31 | $3,211,008 | 118,400 | Put | Other | 2025-02-14 | |
| 2024-12-31 | $2,212,992 | 81,600 | Call | Other | 2025-02-14 | |
| 2024-09-30 | $4,437,279 | 101,100 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $1,575,651 | 35,900 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $2,799,348 | 63,781 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,697,398 | 119,618 | Shares | Defined | 2024-08-15 | |
| 2024-06-30 | $6,911,520 | 176,000 | Call | Defined | 2024-08-15 | |
| 2024-06-30 | $6,742,659 | 171,700 | Put | Defined | 2024-08-15 | |
| 2024-03-31 | $3,505,605 | 81,792 | Shares | Defined | 2024-05-07 | |
| 2024-03-31 | $11,919,366 | 278,100 | Call | Defined | 2024-05-07 | |
| 2024-03-31 | $6,347,566 | 148,100 | Put | Defined | 2024-05-07 | |
| 2023-12-31 | $3,631,716 | 89,100 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $5,563,740 | 136,500 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $476,973 | 11,702 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||